4D Molecular Therapeutics Inc Net Asset Quality Index
4D Molecular Therapeutics Inc net asset quality index. 4D Molecular Therapeutics Inc (FDMT) has a Net Asset Quality Index of 89.2% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $566.71 Million minus total liabilities of $61.05 Million yields net assets of $505.66 Million. A higher index indicates a stronger, lower-leverage balance sheet. See 4D Molecular Therapeutics Inc (FDMT) shareholders funds for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of 4D Molecular Therapeutics Inc (2017–2025)
Net asset quality index of 4D Molecular Therapeutics Inc from 2017 to 2025. This chart shows how 4D Molecular Therapeutics Inc's Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of December 2025, the index stands at 89.2%, representing net assets of $505.66 Million against total assets of $566.71 Million USD. Check 4D Molecular Therapeutics Inc (FDMT) strategic investment index to assess the company's strategic physical and investment asset allocation.
4D Molecular Therapeutics Inc Net Asset Quality Index by Year (2017–2025)
4D Molecular Therapeutics Inc net asset quality index by year from 2017 to 2025. The table below presents the year-by-year Net Asset Quality Index for 4D Molecular Therapeutics Inc from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see FDMT stock market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 89.2% | $505.66 Million | $566.71 Million | $61.05 Million | ▼ -1.9 pp |
| 2024 | 91.1% | $510.61 Million | $560.38 Million | $49.78 Million | ▲ +0.6 pp |
| 2023 | 90.6% | $307.83 Million | $339.89 Million | $32.06 Million | ▲ +2.2 pp |
| 2022 | 88.3% | $231.34 Million | $261.85 Million | $30.51 Million | ▼ -1.9 pp |
| 2021 | 90.3% | $319.11 Million | $353.49 Million | $34.38 Million | ▲ +1.4 pp |
| 2020 | 88.9% | $256.39 Million | $288.33 Million | $31.94 Million | ▲ +214.2 pp |
| 2019 | -125.3% | $-72.97 Million | $58.23 Million | $131.20 Million | ▼ -96.9 pp |
| 2018 | -28.4% | $-27.59 Million | $96.97 Million | $124.56 Million | ▲ +43.3 pp |
| 2017 | -71.7% | $-19.59 Million | $27.32 Million | $46.91 Million | — |